Home
Storia in 1 fonti
VIDEO: Chemoimmunotherapy regimen extends PFS in prostate cancer subset
CHICAGO — In this video from ASCO Annual Meeting, Andrew J. Armstrong, MD, MS, discusses final results of the phase 2 CHAMP trial evaluating a chemoimmunotherapy regimen in neuroendocrine or aggressive-variant metastatic prostate cancer.“This was an effective regimen, and it’s something that now should be studied in randomized, controlled trials to see if we can improve
Raccontata da
healio.com
Timeline cronologica
- ·
VIDEO: Biomarkers, novel treatments among highlights in prostate cancer at ASCO
CHICAGO — In this video, Andre Kydd, MD, PhD, discusses highlights in the field of prostate cancer, including biomarkers of response in treatment and data on new classes of…
- ·
VIDEO: Chemoimmunotherapy regimen extends PFS in prostate cancer subset
CHICAGO — In this video from ASCO Annual Meeting, Andrew J. Armstrong, MD, MS, discusses final results of the phase 2 CHAMP trial evaluating a chemoimmunotherapy regimen in…
- ·
VIDEO: A-DREAM trial shows promising benefit of ADT interruption in prostate cancer
CHICAGO — In this video, Matthew R. Zibelman, MD, discusses the A-DREAM trial, which found that androgen deprivation therapy interruption resulted in testosterone recovery for…